EMG
BSX icon

Ellington Management Group’s Boston Scientific BSX Stock Holding History

Ellington Management Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-25,200
Closed -$1.08M – 604
2019
Q2 		$1.08M Buy
+25,200
New +$969K 0.19% 127
2018
Q1 		– Sell
-12,500
Closed -$310K – 827
2017
Q4 		$310K Buy
+12,500
New +$345K 0.05% 359

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Ellington Management Group's BSX Position: Q3 2019 in Review

Ellington Management Group sold out of Boston Scientific (BSX) in Q3 2019, closing a stake of 25,200 shares — an estimated $1.08M sold.

Ellington Management Group first reported a position in BSX in Q4 2017 and held it in 2 quarters. The position peaked at $1.08M in Q2 2019. 770 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Ellington Management Group reported no remaining Boston Scientific position as of Q3 2019 after selling out during the quarter.
  • Ellington Management Group sold 25,200 Boston Scientific shares in Q3 2019, an estimated $1.08M.
  • Ellington Management Group first reported a position in Boston Scientific in Q4 2017 and held it in 2 quarters.
  • Ellington Management Group's Boston Scientific position peaked at $1.08M in Q2 2019.
  • 770 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Ellington Management Group's 13F filing for Q3 2019, filed 14 Nov 2019.